Beta Bionics Secures $100 Million in Series D Funding to Advance Diabetes Technology and Expand Market Presence
CONCORD, MA / ACCESSWIRE / August 30, 2023 / Beta Bionics, Inc., a pioneering leader in the development of advanced...
Bionic
Pixium Vision announces the implementation of a bridge financing with Bpifrance and Sofinnova and a reverse stock split on the basis of 1 new share for 50 existing shares
Pixium Vision announces the implementation of a bridge financing with Bpifrance and Sofinnova and a reverse stock split on the...
Pixium Vision announces its consolidated financial statements for the financial year 2022 and the consolidated cash balance for March 31, 2023
Pixium Vision announces its consolidated financial statements for the financial year 2022 and the consolidated cash balance for March 31,...
Clearside Biomedical Enhances Scientific Advisory Board with the Appointment of Two Distinguished Retinal Physicians
ALPHARETTA, Ga., April 05, 2023 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to...
Pixium Vision announces FDA Breakthrough Device Designation for the Prima System in Dry AMD
Pixium Vision announces FDA Breakthrough Device Designation for the Prima System in Dry AMD Pixium Vision to receive interactive communication...
Pixium Vision welcomes judgment by Paris Commercial Court against Second Sight Medical Products
Pixium Vision welcomes judgment by Paris Commercial Court against Second Sight Medical Products Court finds Second Sight Medical Products breached 2021...
Syncona Limited Portfolio Company Successfully Completes Tender Offer and Acquisition of Applied Genetic Technologies Corporation
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Dec. 01, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (“AGTC” or the “Company”) (Nasdaq:...
Syncona Limited Portfolio Company Extends Tender Offer to Acquire Applied Genetic Technologies Corporation
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Nov. 29, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (“AGTC” or the “Company”) (Nasdaq:...
Applied Genetic Technologies Corporation Reminds Shareholders to Tender Their Shares by November 28, 2022
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), President and Chief...
Pixium Vision announces its cash position at 30 September 2022 and provides an update on its activities
Pixium Vision announces its cash position at 30 September 2022 and provides an update on its activities Paris, 21 October...
AGTC Receives Positive Type C Meeting Feedback from the FDA for the Company’s Design and Operating Procedures of its Planned cGMP Manufacturing Facility
— FDA feedback marks a key milestone in the construction of the facility expected to support AGTC’s pipeline, including the...
Pixium Vision announces its financial results for H1 2022 and provides a business update
Pixium Vision announces its financial results for H1 2022 and provides a business update Cash position at 30 June 2022:...
Luke the Bionic Arm is Helping Amputees Feel Whole Again
Scientists have developed another remarkable innovation that’s helping amputees gain a new lease on life. Once again, researchers have developed...